Inferring tumor-specific cancer dependencies through integrating ex vivo drug response assays and drug-protein profiling.
PLoS computational biology, 2022
doi:10.1371/journal.pcbi.1010438.
PLoS computational biology, 2022
doi:10.1371/journal.pcbi.1010438.